Free Trial
→ A grave, grave error. (From Porter & Company) (Ad) Free SNY Stock Alerts

Sanofi (SNY) SEC Filings & 10K Form

Sanofi logo
$49.35 -0.13 (-0.26%)
Closing price 04:00 PM Eastern
Extended Trading
$49.12 -0.23 (-0.46%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Sanofi SEC Filings

Export to Excel
DateFilerForm TypeView
07/22/2025
7:49 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2025
5:03 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2025
5:04 AM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T/A
07/10/2025
5:04 AM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T/A
07/02/2025
7:25 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2025
3:49 PM		Sanofi (Filer)
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/24/2025
7:31 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2025
5:43 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
7:33 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
5:07 AM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T
06/06/2025
10:35 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
4:11 PM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-C
06/02/2025
5:09 AM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-C
06/02/2025
5:07 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2025
9:51 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2025
7:09 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2025
9:55 AM		Sanofi (Filer)
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
05/12/2025
3:50 PM		Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SCHEDULE 13G/A
05/06/2025
5:15 AM		Sanofi (Filer)
Sanofi (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
05/05/2025
12:12 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
1:50 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2025
5:48 PM		Innate Pharma SA (Subject)
Innate Pharma SA (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SCHEDULE 13G/A
04/24/2025
9:13 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2025
6:39 PM		BlackRock, Inc. (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SCHEDULE 13G/A
04/22/2025
11:29 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
8:18 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2025
5:11 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2025
7:43 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2025
5:15 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
12:39 PM		Sanofi (Filer)
Sanofi (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2025
10:56 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2025
5:04 AM		Sanofi (Filer)
Sanofi (Filer)
Form S-8 POS
03/20/2025
10:06 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
11:23 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
9:24 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
5:14 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2025
11:18 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
11:14 AM		Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:28 AM		Sanofi (Filer)
Sanofi (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/13/2025
1:11 PM		Sanofi (Filer)
Sanofi (Filer)
Form IRANNOTICE
02/13/2025
12:41 PM		Sanofi (Filer)
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
[No Brainer Gold Play]: “Show me a better investment.” (Ad)

A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Click here to get Garrett’s Top Four picks now.
02/13/2025
11:23 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2025
10:14 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
11:14 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
8:50 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2025
5:04 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
7:40 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
1:08 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
5:07 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2024
10:07 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
11:23 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
1:49 PM		Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SC 13G/A
11/07/2024
10:35 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
5:56 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
11:39 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
10:47 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
2:35 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
10:06 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
1:51 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
11:46 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
9:46 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
8:06 AM		MeiraGTx Holdings plc (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC 13G/A
08/13/2024
5:30 AM		MeiraGTx Holdings plc (Issuer)
Sanofi (Reporting)
Sanofi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2024
5:05 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SNY) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Treasury Secretary Bessent Is Betting Big on Gold
When the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...
Golden Portfolio | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Turn $1K into $50K with This DeFi Gem
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...
Crypto 101 Media | Sponsored
How to Collect Up To $5,917/mo From Trump’s Made In USA Boom
How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...
Investors Alley | Sponsored
Special gold investment soars 2,300% ... 5,090% ... 9,850%
In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...
Weiss Ratings | Sponsored